Pharma IQ | 08/08/2010
Although more than a thousand bacterial genomes have been sequenced, our understanding of bacterial transcriptomes has lagged far behind. Transcript structure, operon linkages, and absolute mRNA abundance information all provide valuable insights into gene function and regulation, but these aspects of the prokaryotic transcriptome have only been explored on a large scale in a few instances. In this Pharma IQ interview, Dr. Nicholas H. Bergman, Principal Investigator and Genomics Team L...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
DigIT Pharma & Health 2026
September 9 - 11, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More